Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 14.01.2022

United Bankers Plc NOTIFICATION 14.01.2022 at 18:30 UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 14.01.2022 Date 14.01.2022Exchange transaction BuyShare class UNITEDAmount 399Average price/share 14.7000 EURHighest price/share 14.7000 EURLowest price/share 14.7000 EURTotal price 5,865.30 EUR The shares held by United Bankers Plc on 14.01.2022: UNITED 59,942 On behalf of United Bankers Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

Bondholders approve amendment to bond terms and conditions

ADDvise Group AB (publ) (the "Company") today announces the successful completion of the written procedure that was initiated on 16 December 2021 (the "Written Procedure") in relation to the Company's outstanding up to SEK 500,000,000 senior secured bonds with ISIN SE0015222088 (the "Bonds"), that sought approval from bondholders ("Bondholders") for certain amendments to the terms and conditions of the Bonds (the "Proposal"). A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of the bondholders voted in favour to

PLAGAZI ELECTS NEW BOARD MEMBERS DURING EXTRAORDINARY GENERAL MEETING

Plagazi AB (publ) has elected Richard J. Fish (former advisory board), Valerie Dujardin and Jorgo Chatzimarkakis as new members of the Board of Directors at the Extraordinary General Meeting held on the 20.12.2021.Linnea Granberg, Stefan Källander, Gustav Granberg and Peter Schmidt have resigned from their positions as members of the Board of Directors of Plagazi AB (publ), since they are all operational within the company.  Richard J. Fish has held senior positions in private equity, energy and automotive/industrial, ranging from start-ups to well-established companies with a turnover

#22-18 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-17 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Eurowings to further expand its network at Stockholm Arlanda – will launch direct routes to Greece and Cologne this summer

The Lufthansa Group’s low-cost carrier Eurowings continues to have strong faith in the Swedish market and the Stockholm region and is now expanding access with the addition of three European routes from Stockholm Arlanda. The routes to Cologne, Crete and Rhodes, to be launched in early summer, are in addition to the network of routes being launched in conjunction with the set-up of the airline’s new Stockholm base. Eurowings continues its expansion in Sweden and at Stockholm Arlanda Airport. In conjunction with the summer 2022 programme, the German low cost carrier plans to open a new

Correction: OEM International acquires Demesne Electrical Sales Limited Ireland

The acquisition of Demesne Electrical in Ireland is not expected to affect the price on the shares, which was incorrectly written in the earlier press release. OEM International has today acquired Demesne Electrical in Ireland. Demesne is Ireland’s leading independent importer and distributor of electrical control, switchgear, energy saving & installation products. The company has a total revenue of € 20 million with operating profit of € 2,5 million. The head office is located in Dublin with branch offices in Cork in the south of Ireland and Dungannon in Northern Ireland. The company has

Directed share issue registered with the Bolagsverket

Clean Industry Solutions Holding Europe AB's ("CISH") recent directed share issue has now been registered with Bolagsverket. The number of shares in the Company following the registration amounts to 15,313,792 shares and the share capital amounts to SEK 1,506,950.18.The directed share issue increases the number of outstanding shares and votes by 3,125,000 shares to 15,313,792 shares. The share capital increases by SEK 307,514.92 to SEK 1,506,950.18, corresponding to a dilution for existing shareholders of approximately 20.4% of the number of shares and votes in the Company. This

Investor AB’s Year-End Report 2021 webcast conference call

A webcast conference call will be held on Friday, January 21, 2022, at 13:00 CET. President and CEO Johan Forssell and CFO Helena Saxon will present the Year-End Report 2021. The webcast conference call will be held in English via www.investorab.com. For phone access: +44 33 33 00 08 04, +1 631 913 1422 or +46 8 5664 2651, with the PIN code 83783155#. The presentation will be published on our website after the event, where you can also view the event on-demand. The Year-End Report is expected to be released around 08:15 CET the same day.

NEW STRATEGIC RECRUITS TO HAMLET PHARMA

To continue Hamlet Pharma’s drug development process towards Phase III trials and future commercialization, it is essential to expand our organization. We are therefore gathering a group of ‘’brilliant minds’’ in our very own THINK TANK, consisting of leading experts in the areas of drug development, business development, finance and clinical strategy.The Think Tank format provides a forum for creative discussions and networking, a place where experience and expertise within the company’s major strategic areas will be shared and cross-pollinated. The Think Tank will meet regularly and serve

Notice to Annual General Meeting of SameSystem A/S

Company Announcement No. 2-2022Copenhagen, 14 January 2022 Notice to Annual General Meeting of SameSystem A/S The shareholders of SameSystem A/S are hereby invited to attend the Annual General Meeting scheduled for 31 January 2022 15:00 Attachments · Notice to Annual General Meeting 2022 · Notice to Annual General Meeting in SameSystem A/S with agenda · Proxy and postal vote form · Ordering of admission card · Remuneration report COVID-19 Due to the continued spread of COVID-19 and recommendations from the Danish health authorities, the board of directors

Neles Corporation: Changes in the composition of the Shareholders’ Nomination Board

Neles Corporation, Stock exchange release on January 14, 2022 at 3.30 p.m. EETAlfa Laval AB (publ.) has informed Neles Corporation (“Neles” or the “Company”) that it has sold the shares it held in Neles. Consequently, Emma Adlerton, a member of the Shareholders’ Nomination Board, has today resigned from the Shareholders’ Nomination Board. Pursuant to the Charter of the Shareholders’ Nomination Board, a member nominated by a shareholder is obliged to resign from the Shareholders’ Nomination Board if the shareholder transfers more than half of the shares it held on 1[st] of September which

Oblique Therapeutics is pleased to announce that the United States Patent and Trademark Office has granted a patent for its innovative AbiProt® technology

Press release – New Patent granted Gothenburg, Sweden, 14 January 2022 – Oblique Therapeutics AB today announces that key aspects of its AbiProt® technology for discovering and developing pharmacologically tailored antibodies against clinically important targets has been granted by the USPTO as US Patent No. 11,161,901 B2. The technology uses artificially intelligent molecular probes and mass spectrometry to identify antibody binding sites on clinically relevant targets, many of which have been considered undruggable with antibodies. The AbiProt® proteomics technology from Oblique

AcouSort extends collaboration agreement with Japanese Life Science partner

AcouSort has extended its cooperation agreement with a major Japanese industrial player regarding the leasing of a new AcouWash 2 system and continuing the ongoing application support. The first agreement was signed in 2019 and is now being extended for yet another year. The extension will generate revenue for AcouSort of EUR 35 000 in 2022. Since 2019, AcouSort has worked closely with the research department of a Japanese Life Science company. The collaboration has meant, among other things, that AcouSort has successfully optimized the AcouWash system and developed an application for

Mycronic receives order for an SLX mask writer

Mycronic AB (publ) has received an order for an SLX mask writer from a new customer in Asia. The order value is in the range of USD 3-5 million. Delivery of the system is planned for the second quarter of 2022.The SLX laser mask writer meets rising demand for photomasks for the semiconductor industry and a future need for replacement and modernization. Photomasks manufactured by laser mask writers are of high importance and account for 70-75 percent of all photomasks produced for semiconductor manufacturing. SLX is a new and modern mask writer based on the same technology as Mycronic’s mask

Cantargia reports treatment of first triple negative breast cancer patient in TRIFOUR study

Cantargia AB today reported treatment of the first triple negative breast cancer (TNBC) patient with nadunolimab and chemotherapy in the phase Ib/II clinical trial TRIFOUR. This trial, performed in collaboration with the Spanish Breast Cancer Group, GEICAM, will evaluate nadunolimab in combination with gemcitabine and carboplatin in up to 113 patients. Initially, the trial will focus on the safety of this combination and the first part is expected to be completed within 6-9 months.The interleukin-1 receptor accessory protein (IL1RAP)-binding antibody nadunolimab is Cantargia’s most advanced

Unibet launches new Eagles themed live dealer game

Unibet announces a new exclusive casino game for New Jersey players. Through a partnership with the Philadelphia Eagles, customers can now play an Eagles-branded live dealer casino game created by Evolution Gaming called “Eagles Live Dealer Black Jack”.Kindred Group plc’s (Kindred) sportsbook brand Unibet launches a new themed live dealer game created out of the existing partnership between Unibet and the Philadelphia Eagles. This newest addition is part of a large game portfolio available to Unibet customers, which includes other Eagles-branded games. “Evolution Gaming has created

Endomines appoints new CFO

Endomines appoints new CFO Endomines AB (publ), Stock Exchange Release 14 January 2022 at 13:00 CET   Endomines is pleased to announce that Mikko Sopanen has been appointed and started work as new CFO of the Group effective 10 January 2022.   Sopanen has extensive experience of financial management and corporate funding in both management and executive roles in multiple companies and situations. He has also gained valuable experience of working in different cultures. Sopanen previously served as CFO of mining company Sotkamo Silver Plc and investment company Sievi Capital Plc.

Fully subscribed warrant program in OrganoClick AB

The CEO and senior executives of OrganoClick AB choose to acquire 100 % of the warrants in the incentive program proposed by the Board.Following the decision of the Extraordinary General Meeting on January 12, 2022, OrganoClick AB was able to offer 979,500 warrants to the CEO and senior executives in the form of an incentive program. The Board believes that a personal ownership commitment is to the benefit of the company and the shareholders, while at the same time giving senior executives the opportunity to participate in the value growth they contribute to creating. The option program

Jussi Linnaranta continues as Chair of Metsäliitto Cooperative Board of Directors

Metsä Group Stock Exchange Release 14 January 2022 at 1.00 pm EETThe Board of Directors of Metsä Group’s parent company Metsäliitto Cooperative has in its constituent meeting decided that Jussi Linnaranta M.Sc. (Agriculture and Forestry) continues as the Chair of the Board of Directors. Timo Saukkonen M.Sc. (Agriculture and Forestry) continues as the Vice Chair of the Board of Directors. The compositions of Board of Directors’ committees are the following: · Audit Committee: Ilkka Salonen, Jussi Linnaranta, Mikko Mäkimattila ja Jussi Vanhanen · HR Committee: Taavi Heikkilä, Jussi

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 14.01.2022, 1.00 PMManagers' transactionsViking Line Abp has today January 14:th, 2022 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp.   Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial

Crunchfish Gesture Interaction introduction – Deeply intuitive gestures

Crunchfish develops AI technology for gesture interaction with exceptional performance, optimized for augmented and virtual reality (AR/VR), automotive and the next generation digital interfaces. An introduction to gesture Interaction was the topic of the 2[nd] session of the Survival of the fittest webinar series on January 14[th], 2022.   An introduction to gesture interaction  was the topic of the 2[nd] session in Crunchfish’s Survival of the fittest webinar series . Joakim Nydemark, CEO of Crunchfish

Attana’s presentation from Biotech Showcase 2022 is now available on Attana’s website

January 10–19, Attana is participating in one of the largest biotech conferences in the world – Biotech Showcase. Attana is attending the digital conference and have published a presentation as well as participated in digital one-to-one meetings.The presentation was held in English and primarily focused on Attana’s ongoing diagnostic work and its two business units – Life Science and Diagnostics. The presentation can be accessed on Attana’s website by following this link: Attana – Biotech Showcase 2022 

There are no items matching the current filter
There are no more items matching the current filter
Back to top